Journal of Liver: Disease & TransplantationISSN: 2325-9612

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Microrna-150 and Microrna-101 As Diagnostic Markers for Hepatitis B Virus Related Hepatocellular Carcinoma in Egypt

Background: Hepatocellular carcinoma (HCC) is an increasing difficult problem in Egypt. MicroRNAs are defined as small RNAs that are non-coding RNAs which regulate gene expression after transcription. Circulating microRNAs are promising biological noninvasive markers for cancer.
Aim: The aim of this study was to evaluate miRNAs in Egyptian HBV related Hepatocellular carcinoma and their relation to clinical parameters.
Methods: MiR-150 and miR-101 relative expression were evaluated by real-time quantitative RT-PCR in 70 serum samples (20 from controls, 25 from chronic hepatitis B (CHB) patients and 25 samples from HBV related HCC patients), the diagnosis of HCC was based on typical imaging finding by dynamic computed tomography.
Results: Our results revealed that the serum relative expression levels of circulating miR-150 were lower and miR-101 were higher in patients with HCC when compared with healthy controls and CHB without HCC patients (p<0.0001). By using Receiver operating characteristic curve analyses it was suggested that miR-150 in serum had significant diagnostic value for HCC in chronic HBV patients with 75 % sensitivity and 90 % specificity. Also miR-101 in serum had significant diagnostic value for HCC in chronic HBV patients with 90 % sensitivity and 90 % specificity.
Conclusion: In conclusion, both miR-150 and miR-101 relative expression in serum in patients with HBV-related HCC could be used as noninvasive biomarkers for the early detection of HBVrelated HCC patients.

Special Features

Full Text


Track Your Manuscript

Media Partners